Study Design
vertigo
This controlled study involved two groups of outpatients: patients in the control group received treatment as usual (TAU), consisting of one monthly visit with a treating otolaryngologist and pharmacological treatment specific for vertigo (i.e., anti-vertigo, corticosteroid, prokinetic, diuretic medications), while the experimental group attended biofeedback training. Patients in the experimental group had pharmacological therapy only in the phase immediately before the start of biofeedback, in order to stabilize the acute phase, and during biofeedback they had none. During the three-month follow-up, the experimental group did not receive any biofeedback boosting sessions.